Kahira Pharmaceuticals & Chemical Industries Company (EGX: CPCI)

Market Cap	1.51B
Revenue (ttm)	1.45B
Net Income (ttm)	261.28M
Shares Out	14.93M
EPS (ttm)	17.47
PE Ratio	5.78
Forward PE	n/a
Dividend	12.83 (12.80%)
Ex-Dividend Date	Dec 24, 2024

Volume	14,299
Average Volume	5,596
Open	103.62
Previous Close	103.62
Day's Range	83.10 - 107.00
52-Week Range	60.61 - 119.99
Beta	0.04
RSI	49.36
Earnings Date	Feb 13, 2025

About EGX: CPCI

Kahira Pharmaceuticals & Chemical Industries Company engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt. The company is involved in the provision of chemicals, extracts, veterinary medicines, and pesticides; and packaging and distribution activities. It also exports its products to Iraq, Yemen, Sudan, Somalia, Jordan, Libya, Senegal, Zimbabwe, South Sudan, Mali, and Kenya. Kahira Pharmaceuticals & Chemical Industries Company was founded in 1962 and is headquartered in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 1,883
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: CPCI

Financial Performance

In 2024, CPCI's revenue was 1.36 billion, an increase of 35.38% compared to the previous year's 1.01 billion. Earnings were 246.11 million, an increase of 153.48%.